Author:
Zaraket Hassan,Saito Reiko
Funder
Ministry of Health and Family Welfare
Publisher
Springer Science and Business Media LLC
Reference102 articles.
1. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342(4):225–31.
2. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2016–2017 northern hemisphere influenza season. Wkly Epidemiol Rec. 2016;91(10):121–32.
3. Nguyen-Van-Tam JS, Venkatesan S, Muthuri SG, Myles PR. Neuraminidase inhibitors: who, when, where? Clin Microbiol Infect. 2015;21(3):222–5.
4. Centers for Disease Prevention and Control. Influenza antiviral medications: summary for clinicians. Available from: http://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm (Accessed on 12 June 2016).
5. • Alame MM, Massaad E, Zaraket H. Peramivir: a novel intravenous neuraminidase inhibitor for treatment of acute influenza infections. Front Microbiol. 2016;7. This is a good review for both researchers and clinicians regarding current updates for peramivir. It covers drug design, mode of action, mechanism and current situation on drug resistance, the latest information on side effects, results of clinical trials and post-marketing surveys.
Cited by
78 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献